Skip to content
PRME Prime Medicine, Inc. Common Stock
$3.43 -2.96% -0.11
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRME stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 641.2M
Enterprise value 620.2M
Trailing PE -2.5407407407407
Forward PE -3.7692335
PEG Ratio 0.084691358024691
Enterprise to EBITDA -3.115
Enterprise to revenue 153.745
Price to book MRQ 7.7294116
Price to sales TTM 147.0819

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 4.0M
EBITDA -199135008
Diluted EPS TTM -1.23
Total Cash (MRQ) 135.5M
Current ratio (MRQ) 3.8
Operating Cash Flow (TTM) -156416992

PRME trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRME News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.